MFAP4 and chronic obstructive pulmonary disease: More recently, numerous studies have implicated MFAP4 as a prognostic marker (or biomarker) for assorted cancers, including ovarian3,4, mammary5 and prostate6, as well as hepatic and pulmonary fibrosis7 and chronic obstructive pulmonary disease (COPD)8.